Literature DB >> 26611603

Stereotaxic Surgical Targeting of the Nonhuman Primate Caudate and Putamen: Gene Therapy for Huntington's Disease.

Jodi L McBride1,2,3, Randall L Clark4.   

Abstract

Stereotaxic surgery is an invaluable tool to deliver a variety of gene therapy constructs to the nonhuman primate caudate and putamen in preclinical studies for the genetic, neurodegenerative disorder, Huntington's disease (HD). Here we describe in detail how to perform this technique beginning with a pre-surgical magnetic resonance imaging scan to determine surgical coordinates followed by the stereotaxic surgical injection technique. In addition, we include methodology of a full necropsy including brain and peripheral tissue removal and a standard immunohistochemical technique to visualize the injected gene therapy agent.

Entities:  

Keywords:  Huntington’s disease; Immunohistochemistry; Magnetic resonance imaging; Necropsy; Neurodegeneration; Nonhuman primate; Stereotaxic surgery

Mesh:

Substances:

Year:  2016        PMID: 26611603      PMCID: PMC5962357          DOI: 10.1007/978-1-4939-3271-9_29

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

1.  Apomorphine-induced dyskinesias after excitotoxic caudate-putamen lesions and the effects of neural transplantation in non-human primates.

Authors:  O Isacson; P Hantraye; M Maziere; M V Sofroniew; D Riche
Journal:  Prog Brain Res       Date:  1990       Impact factor: 2.453

2.  Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease.

Authors:  Jodi L McBride; Mark R Pitzer; Ryan L Boudreau; Brett Dufour; Theodore Hobbs; Sergio R Ojeda; Beverly L Davidson
Journal:  Mol Ther       Date:  2011-10-25       Impact factor: 11.454

3.  Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys.

Authors:  Dwaine F Emerich; Christopher G Thanos; Moses Goddard; Stephen J M Skinner; Marilyn S Geany; William J Bell; Briannan Bintz; Patricia Schneider; Yaping Chu; Rangasamy Suresh Babu; Cesario V Borlongan; Kim Boekelheide; Susan Hall; Bronwyn Bryant; Jeffrey H Kordower
Journal:  Neurobiol Dis       Date:  2006-06-14       Impact factor: 5.996

4.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

5.  A primate model of Huntington's disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon.

Authors:  P Hantraye; D Riche; M Maziere; O Isacson
Journal:  Exp Neurol       Date:  1990-05       Impact factor: 5.330

6.  Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.

Authors:  D F Emerich; S R Winn; P M Hantraye; M Peschanski; E Y Chen; Y Chu; P McDermott; E E Baetge; J H Kordower
Journal:  Nature       Date:  1997-03-27       Impact factor: 49.962

7.  Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease.

Authors:  L H Burns; P Pakzaban; T W Deacon; A L Brownell; S B Tatter; B G Jenkins; O Isacson
Journal:  Neuroscience       Date:  1995-02       Impact factor: 3.590

8.  Neuropathological classification of Huntington's disease.

Authors:  J P Vonsattel; R H Myers; T J Stevens; R J Ferrante; E D Bird; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1985-11       Impact factor: 3.685

9.  Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates.

Authors:  Stéphane Palfi; Emmanuel Brouillet; Béchir Jarraya; Jocelyne Bloch; Caroline Jan; Masahiro Shin; Françoise Condé; Xiao-Jiang Li; Patrick Aebischer; Philippe Hantraye; Nicole Déglon
Journal:  Mol Ther       Date:  2007-05-01       Impact factor: 11.454

10.  Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum.

Authors:  Richard Grondin; Michael D Kaytor; Yi Ai; Peter T Nelson; Deepak R Thakker; Jennifer Heisel; Marcy R Weatherspoon; Janelle L Blum; Eric N Burright; Zhiming Zhang; William F Kaemmerer
Journal:  Brain       Date:  2012-01-16       Impact factor: 13.501

View more
  2 in total

1.  Nonhuman Primate Models of Neurodegenerative Disorders.

Authors:  Marina E Emborg
Journal:  ILAR J       Date:  2017-12-01

2.  Attitudes of Potential Participants Towards Molecular Therapy Trials in Huntington's Disease.

Authors:  Tanya M Bardakjian; Kaylee Faulkner Naczi; Pedro Gonzalez-Alegre
Journal:  J Huntingtons Dis       Date:  2019
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.